Shi G, Wu J, Wang P, Song M, Sun L, Tu YJ, Huang XD. Expression of RhoGDI2 and 14-3-3σ in gastric carcinoma.
Shijie Huaren Xiaohua Zazhi 2015;
23:5282-5289. [DOI:
10.11569/wcjd.v23.i33.5282]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To detect the expression of RhoGDI2 and 14-3-3σ in gastric cancer, analyze their correlation with clinicopathological characteristics of gastric cancer, and assess their correlation.
METHODS: Immunohistochemistry was used to detect the expression of RhoGDI2 and 14-3-3σ in 152 gastric cancer specimens.
RESULTS: The positive rates of RhoGDI2 and 14-3-3σ in gastric cancer were 76.97% and 27.63%, respectively. The expression of RhoGDI2 and 14-3-3σ was related with tumor differentiation, depth of invasion, lymph node metastasis, distant metastasis and TNM stage in gastric cancer. There was a negative correlation between the expression of RhoGDI2 and 14-3-3σ in gastric cancer.
CONCLUSION: There is a correlation between the expression of RhoGDI2 and 14-3-3σ in gastric cancer. 14-3-3σ is very likely regulated by RhoGDI2 and functions as a downstream target gene of RhoGDI2 in tumor invasion and metastasis. They may be both involved in regulating the invasion and metastasis of gastric cancer.
Collapse